1. topiramate -- score = 3.59406090127
	topiramate treatment -- 8
	topiramate group -- 7
	topiramate users -- 3
	topiramate therapy -- 3
	topiramate withdrawal -- 2
	low-dose topiramate -- 2
	prophylactic topiramate treatment -- 1
	daily topiramate dose -- 1
	long-term topiramate administration -- 1
	topiramate induced secondary acute angle closure glaucoma -- 1
2. prophylaxis -- score = 3.59406090127
	migraine prophylaxis -- 45
	medical prophylaxis -- 7
	pharmacological prophylaxis -- 3
	chronic migraine prophylaxis -- 3
	short-term prophylaxis -- 2
	prophylaxis -- 2
	headache prophylaxis -- 2
	research evaluating migraine prophylaxis therapy -- 2
	phase III research evaluating migraine prophylaxis therapy program PREEMPT -- 1
	rapid onset effective prophylaxis -- 1
3. migraine -- score = 3.59406090127
	chronic migraine -- 394
	migraine patients -- 351
	migraine attacks -- 191
	migraine headache -- 174
	episodic migraine -- 150
	vestibular migraine -- 110
	migraine headaches -- 96
	migraine pathophysiology -- 51
	hemiplegic migraine -- 51
	migraine attack -- 50
4. headache -- score = 3.45893986189
	migraine headache -- 174
	tension-type headache -- 157
	headache disorders -- 118
	migraine headaches -- 96
	headache frequency -- 95
	primary headaches -- 86
	cluster headache -- 83
	headache days -- 62
	primary headache -- 50
	chronic headache -- 47
5. STUDY -- score = 3.19423674872
	further studies -- 46
	future studies -- 35
	few studies -- 24
	previous studies -- 23
	clinical studies -- 23
	STUDY DESIGN -- 20
	several studies -- 20
	recent studies -- 17
	prospective studies -- 9
	observational studies -- 9
6. patients -- score = 3.19200959265
	migraine patients -- 351
	patients -- 141
	pediatric patients -- 30
	chronic migraine patients -- 28
	many patients -- 22
	consecutive patients -- 20
	adult patients -- 18
	aura patients -- 17
	MOH patients -- 11
	mwoa patients -- 11
7. pain -- score = 3.07918124605
	chronic pain -- 58
	pain intensity -- 47
	migraine pain -- 44
	abdominal pain -- 33
	pain relief -- 27
	neuropathic pain -- 26
	neck pain -- 23
	pain modulation -- 18
	facial pain -- 17
	severe pain -- 15
8. treatment -- score = 3.07845681805
	prophylactic treatment -- 53
	acute treatment -- 53
	preventive treatment -- 36
	migraine treatment -- 34
	effective treatment -- 20
	treatment options -- 19
	acute migraine treatment -- 16
	prophylactic treatments -- 13
	medical treatment -- 12
	surgical treatment -- 11
9. clinical -- score = 3.01029995664
	clinical features -- 73
	clinical trials -- 65
	clinical characteristics -- 47
	clinical trial -- 33
	clinical practice -- 32
	clinical studies -- 23
	clinical data -- 21
	clinical presentation -- 21
	clinical efficacy -- 16
	clinical outcomes -- 12
10. disorders -- score = 2.98587535731
	headache disorders -- 118
	neurological disorders -- 57
	primary headache disorders -- 36
	neurological disorder -- 28
	mood disorders -- 26
	gastrointestinal disorders -- 26
	bipolar disorder -- 23
	vestibular disorders -- 20
	temporomandibular disorders -- 18
	headache disorder -- 14
11. chronic -- score = 2.976349979
	chronic migraine -- 394
	chronic pain -- 58
	chronic headache -- 47
	chronic migraine patients -- 28
	chronic conditions -- 28
	chronic headaches -- 18
	chronic migraineurs -- 18
	chronic cluster headache -- 16
	refractory chronic migraine -- 12
	chronic pain conditions -- 11
12. groups -- score = 2.97543180851
	control groups -- 19
	age groups -- 12
	migraine groups -- 11
	groups -- 11
	patient groups -- 10
	other groups -- 6
	treatment groups -- 6
	different groups -- 3
	placebo groups -- 3
	standard groups -- 3
13. attacks -- score = 2.85247999364
	migraine attacks -- 191
	migraine attack -- 50
	attack frequency -- 33
	headache attacks -- 24
	ischemic attacks -- 17
	headache attack -- 13
	spontaneous migraine attacks -- 13
	attack duration -- 11
	ischemic attack -- 11
	stroke-like migraine attacks -- 11
14. medical -- score = 2.82477646248
	medication overuse -- 40
	medication overuse headache -- 26
	medical history -- 23
	medical conditions -- 22
	rescue medication -- 16
	prophylactic medications -- 14
	medical students -- 14
	medical treatment -- 12
	medication use -- 11
	preventive medications -- 11
15. effect -- score = 2.79448804666
	adverse effects -- 35
	side effects -- 25
	effective treatment -- 20
	long-term effects -- 9
	significant effect -- 9
	anti-inflammatory effects -- 8
	analgesic effect -- 7
	effective treatments -- 6
	inhibitory effect -- 6
	adverse effect -- 6
16. disease -- score = 2.79169064902
	cardiovascular disease -- 27
	neurological diseases -- 27
	disease duration -- 17
	coronary artery disease -- 15
	dry eye disease -- 13
	cardiovascular diseases -- 12
	disease severity -- 11
	chronic diseases -- 10
	neurological disease -- 9
	cerebrovascular disease -- 9
17. control -- score = 2.76715586608
	control group -- 127
	healthy controls -- 120
	controlled trials -- 27
	control subjects -- 20
	control groups -- 19
	normal controls -- 13
	healthy control subjects -- 11
	healthy control group -- 9
	controlled trial -- 9
	sex-matched controls -- 8
18. symptom -- score = 2.74741180789
	migraine symptoms -- 27
	neurological symptoms -- 23
	vestibular symptoms -- 18
	headache symptoms -- 14
	premonitory symptoms -- 13
	depressive symptoms -- 13
	somatic symptoms -- 10
	psychological symptoms -- 9
	anxiety symptoms -- 9
	clinical symptoms -- 8
19. different -- score = 2.70586371228
	significant difference -- 63
	mean difference -- 16
	different types -- 15
	different phases -- 5
	different doses -- 5
	different regions -- 5
	different stages -- 4
	different organs -- 4
	statistical difference -- 4
	different time points -- 3
20. significant -- score = 2.69897000434
	significant differences -- 66
	significant difference -- 63
	significant improvement -- 29
	significant association -- 22
	significant reduction -- 21
	significant increase -- 21
	significant decrease -- 20
	significant correlation -- 10
	significant effect -- 9
	significant impact -- 9
21. brain -- score = 2.69460519893
	traumatic brain injury -- 39
	brain regions -- 17
	brain structure -- 11
	brain magnetic resonance imaging -- 8
	brain function -- 7
	migraine brain -- 7
	rat brain -- 7
	human brain -- 7
	brain stem -- 7
	brain tumors -- 6
22. functional -- score = 2.68484536164
	functional connectivity -- 45
	functional dizziness -- 10
	functional changes -- 10
	functional dyspepsia -- 10
	functional gastrointestinal disorders -- 9
	functional activity -- 7
	functional disorders -- 6
	physiological functions -- 5
	cognitive functions -- 5
	physical functioning -- 5
23. factors -- score = 2.67760695272
	risk factors -- 63
	risk factor -- 39
	psychological factors -- 19
	vascular risk factors -- 10
	environmental factors -- 9
	neurotrophic factor -- 9
	other factors -- 8
	familial factors -- 7
	psychosocial factors -- 7
	independent risk factor -- 7
24. activation -- score = 2.66838591669
	physical activity -- 16
	trigeminovascular activation -- 14
	daily activities -- 13
	trigeminal activation -- 9
	neuronal activity -- 8
	endothelial activation -- 8
	active trps -- 7
	functional activity -- 7
	analgesic activity -- 6
	active compounds -- 6
25. system -- score = 2.65030752313
	nervous system -- 59
	trigeminovascular system -- 33
	trigeminal system -- 21
	systemic administration -- 13
	visual system -- 7
	endocannabinoid system -- 5
	systemic exposure -- 5
	cardiovascular system -- 5
	vestibular system -- 5
	glymphatic system -- 5
26. risk -- score = 2.6232492904
	risk factors -- 63
	risk factor -- 39
	stroke risk -- 16
	increased risk -- 13
	migraine risk -- 10
	high risk -- 10
	vascular risk factors -- 10
	relative risk -- 8
	independent risk factor -- 7
	risk ratio -- 7
27. primary -- score = 2.61595005166
	primary headaches -- 86
	primary headache -- 50
	primary headache disorders -- 36
	primary outcome -- 20
	primary care -- 16
	primary headache disorder -- 13
	primary endpoint -- 13
	primary outcome measure -- 10
	primary afferents -- 7
	primary aim -- 5
28. receptor -- score = 2.60422605308
	CGRP receptor -- 22
	CGRP receptors -- 15
	opioid receptors -- 9
	receptor-like receptor -- 5
	transient receptor potential -- 5
	receptors -- 5
	5-HT receptors -- 5
	5-HT1B receptor binding -- 5
	CGRP receptor antagonists -- 4
	P2X7 receptors -- 4
29. levels -- score = 2.58206336291
	plasma levels -- 13
	serum levels -- 11
	high levels -- 10
	levels -- 10
	CGRP levels -- 8
	low levels -- 5
	protein levels -- 5
	leptin levels -- 4
	serum calcium levels -- 4
	expression levels -- 4
30. drug -- score = 2.56820172407
	antiepileptic drugs -- 17
	drug administration -- 15
	anti-inflammatory drugs -- 12
	anti-migraine drugs -- 9
	prophylactic drugs -- 8
	drug use -- 6
	other drugs -- 6
	anti-inflammatory drug -- 6
	antiepileptic drug -- 6
	preventive drugs -- 4
31. severe -- score = 2.56584781867
	headache severity -- 28
	several studies -- 20
	migraine severity -- 19
	severe pain -- 15
	severe headache -- 14
	pain severity -- 11
	disease severity -- 11
	symptom severity -- 7
	severe headaches -- 6
	severe headache days -- 5
32. neurological -- score = 2.56110138365
	neurological disorders -- 57
	neurological disorder -- 28
	neurological diseases -- 27
	neurological symptoms -- 23
	neurological conditions -- 10
	neurological disease -- 9
	neurological examination -- 9
	neurological manifestations -- 8
	neurological condition -- 8
	neurologic manifestations -- 7
33. therapy -- score = 2.55990662504
	behavioral therapy -- 14
	prophylactic therapy -- 11
	preventive therapy -- 10
	therapy -- 9
	radiation therapy -- 8
	acute migraine therapy -- 7
	migraine therapy -- 7
	cognitive-behavioral therapy -- 6
	manipulative therapy -- 6
	abortive therapy -- 5
34. models -- score = 2.55266821611
	animal models -- 14
	experimental models -- 9
	human models -- 6
	logistic regression models -- 5
	linear models -- 4
	linear regression models -- 4
	preclinical models -- 3
	structural models -- 2
	mouse models -- 2
	mixed models -- 2
35. mechanisms -- score = 2.55022835306
	pathophysiological mechanisms -- 13
	underlying mechanisms -- 12
	mechanical thresholds -- 7
	mechanical allodynia -- 6
	mechanical stimuli -- 6
	potential mechanisms -- 6
	possible mechanism -- 6
	biological mechanisms -- 6
	pathophysiological mechanism -- 6
	pathological mechanisms -- 5
36. ANALYSIS -- score = 2.54654266348
	DATA COLLECTION AND ANALYSIS -- 7
37. conditions -- score = 2.54157924395
	chronic conditions -- 28
	medical conditions -- 22
	chronic pain conditions -- 11
	comorbid conditions -- 11
	neurological conditions -- 10
	pain conditions -- 8
	physical health conditions -- 8
	common conditions -- 8
	other conditions -- 7
	headache conditions -- 6
38. health -- score = 2.53781909507
	mental health -- 15
	health problems -- 10
	health care providers -- 9
	physical health conditions -- 8
	national health -- 6
	health risk behaviors -- 6
	health study -- 6
	public health -- 5
	self-rated health -- 5
	adult health -- 5
39. acute -- score = 2.53275437899
	acute treatment -- 53
	acute migraine -- 31
	acute migraine treatment -- 16
	acute migraine headache -- 10
	acute attacks -- 10
	acute medication -- 10
	acute migraine attacks -- 10
	acute migraine therapy -- 7
	acute headache -- 6
	acute herpes zoster -- 6
40. episodes -- score = 2.53275437899
	episodic migraine -- 150
	recurrent episodes -- 8
	episodic migraine patients -- 8
	episodic migraineurs -- 8
	episodic ataxia -- 6
	episodic migraines -- 5
	episodic TTH -- 5
	migraine episodes -- 5
	episodic vertigo -- 5
	first episode -- 4
41. syndrome -- score = 2.52244423351
	irritable bowel syndrome -- 38
	legs syndrome -- 14
	antiphospholipid syndrome -- 11
	SMART syndrome -- 10
	cerebral vasoconstriction syndrome -- 9
	wonderland syndrome -- 8
	pain syndromes -- 7
	metabolic syndrome -- 7
	serotonin syndrome -- 6
	cyclic vomiting syndrome -- 6
42. trial -- score = 2.51851393988
	clinical trials -- 65
	clinical trial -- 33
	controlled trials -- 27
	TRIAL REGISTRATION -- 10
	controlled trial -- 9
	placebo-controlled trials -- 6
	randomized controlled trial -- 4
	trial registration -- 4
	sham-controlled trial -- 4
	phase III trials -- 4
43. DATA -- score = 2.51587384371
	DATA COLLECTION AND ANALYSIS -- 7
	DATA SOURCES -- 2
	DATA EXTRACTION -- 1
44. frequency -- score = 2.51454775266
	headache frequency -- 95
	migraine frequency -- 39
	attack frequency -- 33
	high frequency -- 9
	migraine attack frequency -- 6
	low frequency -- 5
	increased frequency -- 4
	genotype frequencies -- 4
	headache attack frequency -- 4
	pain frequency -- 3
45. vestibular -- score = 2.50920252233
	vestibular migraine -- 110
	vestibular disorders -- 20
	vestibular symptoms -- 18
	vestibular rehabilitation -- 12
	vestibular neuritis -- 9
	vestibular migraine patients -- 6
	vestibular syndrome -- 6
	vestibular function tests -- 5
	vestibular dysfunction -- 5
	vestibular system -- 5
46. others -- score = 2.50920252233
	whereas others -- 1
	others HIV patients -- 1
	many others -- 1
47. stimulation -- score = 2.5078558717
	magnetic stimulation -- 23
	occipital nerve stimulation -- 17
	non-invasive vagus nerve stimulation -- 13
	electrical stimulation -- 13
	dural stimulation -- 11
	visual stimulation -- 11
	current stimulation -- 10
	sham stimulation -- 9
	spinal cord stimulation -- 6
	noxious stimulation -- 5
48. testing -- score = 2.50379068306
	genetic testing -- 8
	vestibular function tests -- 5
	blood tests -- 3
	cognitive testing -- 3
	vestibular testing -- 3
	chi-square tests -- 3
	multiple testing -- 3
	neurocognitive testing -- 3
	diagnostic tests -- 3
	medical tests -- 3
49. meaning -- score = 2.50105926222
	marginal means -- 2
	essential meaning -- 1
	double meaning -- 1
	therapeutic means -- 1
50. nerve -- score = 2.50105926222
	occipital nerve -- 17
	occipital nerve stimulation -- 17
	non-invasive vagus nerve stimulation -- 13
	trigeminal nerve -- 10
	peripheral nerve blocks -- 10
	retinal nerve fiber layer -- 9
	nerve blocks -- 8
	occipital nerves -- 7
	occipital nerve block -- 6
	optic nerve -- 5
51. populations -- score = 2.48995847942
	general population -- 76
	study population -- 12
	patient population -- 8
	population -- 8
	pediatric population -- 6
	adult population -- 6
	population level -- 5
	migraine population -- 4
	chinese population -- 4
	kuwaiti population -- 4
52. trigeminal -- score = 2.4814426285
	trigeminal ganglion -- 30
	trigeminal ganglia -- 29
	trigeminal nucleus caudalis -- 29
	trigeminal system -- 21
	trigeminal neuralgia -- 11
	trigeminal nerve -- 10
	trigeminal activation -- 9
	trigeminal neurons -- 8
	trigeminal nucleus -- 7
	trigeminal area -- 6
53. visual -- score = 2.48000694296
	visual aura -- 34
	visual analogue scale -- 16
	visual cortex -- 14
	visual snow -- 12
	visual stimulation -- 11
	visual field -- 9
	visual analog scale -- 9
	visual vertical -- 8
	visual stimuli -- 7
	visual impairment -- 7
54. outcomes -- score = 2.48000694296
	secondary outcomes -- 12
	clinical outcomes -- 12
	MAIN OUTCOME MEASURES -- 10
	main outcomes -- 6
	headache outcomes -- 5
	primary outcomes -- 5
	MAIN OUTCOME MEASURE -- 4
	functional outcomes -- 4
	treatment outcomes -- 4
	migraine outcomes -- 4
55. scores -- score = 2.46982201598
	VAS scores -- 10
	pain scores -- 9
	depression scores -- 6
	subscale scores -- 5
	anxiety scores -- 4
	MIDAS scores -- 3
	HIT-6 scores -- 3
	high depression scores -- 2
	scoring system -- 2
	mean scores -- 2
56. change -- score = 2.46834733041
	structural changes -- 11
	functional changes -- 10
	lifestyle changes -- 7
	significant change -- 7
	change -- 6
	MRI changes -- 5
	longitudinal changes -- 5
	vascular changes -- 5
	significant changes -- 5
	status change -- 4
57. potentials -- score = 2.45788189673
	evoked potentials -- 11
	potential role -- 8
	potential mechanisms -- 6
	potential association -- 6
	transient receptor potential -- 5
	potential treatment -- 5
	potential confounders -- 5
	potential relevance -- 5
	therapeutic potential -- 4
	potential use -- 4
58. reviews -- score = 2.45331834005
	PURPOSE REVIEW -- 27
	systematic reviews -- 10
	complete reviews -- 2
	new reviews -- 2
	systematic reviews published -- 2
	recent reviews -- 1
	reviewed studies -- 1
	retrospective case reviews -- 1
	physician reviewers -- 1
	independent reviewers -- 1
59. healthy -- score = 2.44870631991
	healthy controls -- 120
	healthy subjects -- 40
	healthy volunteers -- 27
	healthy individuals -- 16
	healthy control subjects -- 11
	healthy women -- 10
	healthy control group -- 9
	healthy adults -- 6
	healthy participants -- 4
	healthy population -- 4
60. responses -- score = 2.44404479592
	neuronal responses -- 4
	vasopressor responses -- 3
	pupil responses -- 3
	potential responses -- 3
	affect responses -- 2
	stress responses -- 2
	photic responses -- 2
	tachycardic responses -- 2
	trigeminovascular system responses -- 1
	dural vasdilatory responses -- 1
61. neurons -- score = 2.43775056282
	neurons -- 26
	sensory neurons -- 13
	neuronal activity -- 8
	trigeminal neurons -- 8
	neuronal firing -- 7
	neuronal excitability -- 7
	trigeminovascular neurons -- 7
	vc/c1 neurons -- 6
	trigeminal ganglion neurons -- 5
	neuronal activation -- 5
62. cases -- score = 2.42160392687
	cases -- 8
	many cases -- 8
	migraine cases -- 6
	CASE REPORT -- 6
	other cases -- 4
	CASE PRESENTATION -- 4
	few cases -- 3
	CASE DESCRIPTION -- 3
	refractory cases -- 2
	clinical cases -- 2
63. age -- score = 2.41664050734
	mean age -- 115
	age group -- 16
	median age -- 14
	age groups -- 12
	average age -- 12
	school age -- 9
	reproductive age -- 6
	age range -- 5
	gestational age -- 4
	pediatric age group -- 3
64. CRITERIA -- score = 2.41329976408
	SELECTION CRITERIA -- 7
65. days -- score = 2.41161970596
	headache days -- 62
	migraine days -- 41
	monthly migraine days -- 15
	monthly headache days -- 6
	first day -- 5
	days -- 5
	severe headache days -- 5
	consecutive days -- 5
	medication days -- 4
	headache-free days -- 4
66. useful -- score = 2.40483371662
	useful tool -- 6
	useful information -- 2
	clinical usefulness -- 2
	useful approach -- 2
	used medication -- 2
	useful treatment -- 1
	useful headache treatments -- 1
	used treatments -- 1
	method using questionnaires -- 1
	acupuncturist uses sterile needles -- 1
67. EVENT -- score = 2.40140054078
	adverse events -- 114
	cardiovascular events -- 9
	vascular events -- 5
	events -- 5
	paroxysmal events -- 3
	cerebrovascular events -- 3
	ischaemic events -- 3
	CSD events -- 3
	ischemic events -- 3
	nonnoxious events -- 2
68. gene -- score = 2.39967372148
	CACNA1A gene -- 12
	gene expression -- 11
	NOTCH3 gene -- 8
	calcitonin gene -- 7
	ATP1A2 gene -- 6
	CACNA1E gene -- 6
	PRRT2 gene -- 4
	gene polymorphisms -- 4
	NEMP genes -- 4
	ESR1 gene -- 4
69. rate -- score = 2.39794000867
	response rate -- 12
	heart rate -- 10
	high rate -- 6
	high rates -- 6
	response rates -- 6
	responder rate -- 5
	positive rate -- 5
	flow rate -- 4
	relapse rates -- 4
	age-standardised rates -- 4
70. types -- score = 2.39445168083
	different types -- 15
	other types -- 14
	various types -- 12
	headache types -- 9
	generalised seizure types -- 4
	seizure types -- 3
	abuse types -- 3
	different headache types -- 3
	primary headache types -- 3
	common types -- 2
71. diagnosis -- score = 2.3909351071
	differential diagnosis -- 31
	correct diagnosis -- 13
	migraine diagnosis -- 13
	diagnosis -- 11
	headache diagnosis -- 10
	clinical diagnosis -- 10
	accurate diagnosis -- 6
	final diagnosis -- 5
	early diagnosis -- 5
	initial diagnosis -- 4
72. common -- score = 2.37106786227
	common causes -- 11
	common conditions -- 8
	common cause -- 7
	common symptom -- 7
	common complaint -- 6
	common type -- 6
	common diseases -- 6
	common diagnoses -- 5
	common disorder -- 5
	common symptoms -- 5
73. aura -- score = 2.36548798489
	migraine aura -- 39
	visual aura -- 34
	aura patients -- 17
	aura group -- 8
	brainstem aura -- 8
	aura attacks -- 7
	aura symptoms -- 7
	typical aura -- 6
	visual auras -- 6
	migraine aura status -- 4
74. evidences -- score = 2.36361197989
	EVIDENCE ACQUISITION -- 4
	CLINICAL QUESTION/LEVEL EVIDENCE -- 2
	fmri evidences -- 1
	indirect evidences -- 1
	up-to-date evidences -- 1
	main evidences -- 1
	additional evidences -- 1
	limited efficacy evidences -- 1
	oxidative stress evident -- 1
75. high -- score = 2.36172783602
	high prevalence -- 18
	high risk -- 10
	high levels -- 10
	high frequency -- 9
	high school students -- 8
	high rate -- 6
	high rates -- 6
	high sensitivity -- 5
	high level -- 5
	high FRS -- 5
76. presented -- score = 2.36172783602
	clinical presentation -- 21
	first presentation -- 4
	CASE PRESENTATION -- 4
	atypical presentation -- 3
	clinical presentations -- 3
	presenting feature -- 3
	headache presentations -- 2
	common presentation -- 2
	initial presentation -- 2
	presenting symptom -- 2
77. preventive -- score = 2.35983548234
	preventive treatment -- 36
	migraine prevention -- 33
	preventive medications -- 11
	preventive therapy -- 10
	preventive treatments -- 8
	preventive medication -- 7
	preventive therapies -- 5
	short-term prevention -- 5
	migraine preventive medications -- 5
	preventive drugs -- 4
78. associations -- score = 2.33645973385
	significant associations -- 9
	associated factors -- 4
	positive associations -- 4
	associated features -- 3
	chronic migraine associated -- 2
	allodynia associated -- 2
	associated costs -- 2
	associated symptoms -- 2
	multivariate associations -- 1
	extensive associations -- 1
79. generalized -- score = 2.32837960344
	general population -- 76
	general practitioners -- 4
	general practice -- 4
	general self-efficacy -- 4
	general consensus -- 3
	generalized anxiety disorder -- 3
	generalized anxiety disorder-7 -- 3
	weakness general tiredness -- 3
	next generation -- 3
	general populations -- 2
80. features -- score = 2.32633586093
	clinical features -- 73
	headache features -- 6
	migraine features -- 5
	characteristic features -- 3
	associated features -- 3
	migrainous features -- 3
	neurological features -- 2
	unique features -- 2
	asthma features -- 2
	autonomic features -- 2
81. history -- score = 2.32633586093
	family history -- 42
	medical history -- 23
	migraine history -- 19
	positive family history -- 8
	natural history -- 8
	familial history -- 6
	headache history -- 5
	lifetime history -- 4
	clinical history -- 4
	concussion history -- 4
82. currents -- score = 2.3242824553
	hnav1.7 currents -- 2
	potassium currents -- 2
	anion currents -- 1
	whereas heaat1 anion currents -- 1
	TRESK currents -- 1
	nahs-induced currents -- 1
	capsaicin-induced currents -- 1
	fast membrane currents -- 1
	inward currents -- 1
83. comorbid -- score = 2.31806333496
	psychiatric comorbidities -- 28
	comorbid conditions -- 11
	comorbid -- 10
	comorbid headaches -- 7
	comorbid depression -- 6
	comorbid migraine -- 6
	additional comorbidities -- 6
	psychiatric comorbidity -- 6
	comorbid anxiety -- 5
	comorbid disorders -- 4
84. imaging -- score = 2.31806333496
	magnetic resonance imaging -- 57
	brain magnetic resonance imaging -- 8
	brain imaging -- 4
	structural image segment -- 4
	diffusion tensor imaging -- 4
	functional imaging -- 3
	diffusion tensor images -- 3
	structure images -- 3
	TOF-MRA images -- 3
	brain structural images -- 3
85. cells -- score = 2.31806333496
	mast cells -- 12
	glial cells -- 10
	endothelial cells -- 9
	sickle cell disease -- 8
	smooth muscle cells -- 6
	ganglion cell layer -- 6
	MDA-MB-231 cells -- 6
	dural mast cells -- 4
	hep3b cells -- 3
	positive cells -- 3
86. stroke -- score = 2.31386722037
	ischemic stroke -- 75
	stroke risk -- 16
	ischaemic stroke -- 11
	cryptogenic stroke -- 8
	hemorrhagic stroke -- 7
	ischemic strokes -- 5
	stroke mimics -- 5
	stroke subtypes -- 4
	acute stroke -- 4
	stroke diagnosis -- 3
87. rats -- score = 2.30963016743
	rat model -- 34
	migraine rats -- 8
	rat brain -- 7
	male rats -- 7
	rats -- 6
	sprague-dawley rats -- 6
	female rats -- 6
	rat cortex -- 4
	rat meninges -- 3
	DMO rats -- 3
88. subjects -- score = 2.30963016743
	healthy subjects -- 40
	control subjects -- 20
	healthy control subjects -- 11
	migraine subjects -- 11
	eligible subjects -- 5
	subjective dizziness -- 5
	IBS subjects -- 5
	vestibular migraine subjects -- 4
	normal control subjects -- 3
	HHT subjects -- 3
89. results -- score = 2.30963016743
	preliminary results -- 6
	positive results -- 6
	present results -- 5
	significant results -- 4
	similar results -- 4
	good results -- 4
	inconsistent results -- 4
	treatment results -- 3
	clinical results -- 3
	negative results -- 3
90. period -- score = 2.30749603791
	follow-up period -- 21
	interictal period -- 19
	wiley periodicals -- 9
	study period -- 8
	attack-free period -- 6
	treatment period -- 6
	attack period -- 5
	first period -- 5
	postpartum period -- 4
	attack-free periods -- 4
91. disability -- score = 2.30749603791
	headache-related disability -- 26
	migraine-related disability -- 19
	migraine disability assessment -- 13
	headache disability -- 9
	migraine disability -- 7
	significant disability -- 6
	disability worldwide -- 6
	migraine disability assessment scale -- 6
	headache disability inventory -- 4
	functional disability -- 4
92. international -- score = 2.29885307641
	international classification -- 78
	international headache society -- 31
	internal consistency -- 17
	international headache society criteria -- 11
	international headache society classification -- 3
	internal HSLC -- 3
	internal carotid artery -- 3
	international headache classification -- 3
	internal carotid artery agenesis -- 2
	internal capsule -- 2
93. family -- score = 2.29885307641
	family history -- 42
	familial hemiplegic migraine -- 14
	positive family history -- 8
	familial factors -- 7
	family caregivers -- 7
	familial predisposition -- 6
	familial history -- 6
	familial hemiplegic migraine type -- 5
	affected family members -- 3
	receptor family -- 3
94. time -- score = 2.29446622616
	first time -- 26
	median time -- 8
	same time -- 7
	mean time -- 6
	follow-up time -- 6
	time points -- 5
	time course -- 5
	long time -- 4
	time interval -- 4
	interview time -- 4
95. first -- score = 2.29446622616
	first time -- 26
	first year -- 12
	first study -- 10
	first month -- 8
	first day -- 5
	first attack -- 5
	first report -- 5
	first period -- 5
	first part -- 5
	first visit -- 5
96. new -- score = 2.29225607136
	new patients -- 7
	new AED -- 5
	new approach -- 5
	new criteria -- 5
	new approaches -- 5
	new evidence -- 4
	new perspective -- 3
	new comorbidity model -- 3
	new method -- 3
	new onset -- 3
97. tension-type -- score = 2.29003461136
	tension-type headache -- 157
	tension-type headaches -- 22
	tension-type headache patients -- 5
	chronic tension-type headache -- 3
	tension-type patients -- 1
	tension-type headache studies -- 1
	tension-type headache diagnosis -- 1
	tension-type headache group -- 1
	tension-type headache INTERVENTIONS -- 1
	tension-type headaches tricyclic antidepressants -- 1
98. researchers -- score = 2.28780172993
	many researchers -- 1
	epidemiological researchers -- 1
	future researches -- 1
	actual researches -- 1
	recent years researchers -- 1
	vivo researches -- 1
	basic researchers -- 1
	migraine researchers -- 1
	trained researchers -- 1
99. scale -- score = 2.28555730901
	visual analogue scale -- 16
	depression scale -- 9
	visual analog scale -- 9
	migraine disability assessment scale -- 6
	0-10 scale -- 5
	perceived stress scale -- 4
	rankin scale -- 4
	stress scale -- 3
	epworth sleepiness scale score -- 3
	numeric rating scale -- 3
100. increase -- score = 2.28555730901
	significant increase -- 21
	increased risk -- 13
	increased odds -- 7
	increased sensitivity -- 6
	increased volume -- 5
	increased frequency -- 4
	increased prevalence -- 4
	increase -- 4
	increased morbidity -- 3
	increased expression -- 3
